All In Biotech

Drug Trial Radar · NCT06152575

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 492 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

492

Planned (sponsor's estimate)

Start

Feb 8, 2024

Primary completion

Aug 26, 2026

Study completion Dec 30, 2027

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Nov 30, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer). This study is seeking participants who: * Are 18 years of age or older and have MM. * Have received treatments before for MM. * Have MM that has returned or not responded to their most recent treatment. Half of the participants will receive elranatamab. The other half of participants will receive a combination therapy selected by the study doctor. The selected combination therapy will include 2 to 3 different medicines commonly used to treat MM. Elranatamab will be given as a shot under the skin at the study clinic about once a week. This may change to a smaller number of shots later in the study. The medicines in the combination therapy will be taken by mouth (at home or at the study clinic) AND will be given either as: * a shot under the skin at the study clinic * through a needle in the vein at the study clinic The number of times these medicines will be taken depends on what combination therapy the study doctor selects. Participants may continue to receive elranatamab or a combination therapy until their MM is no longer responding. The study team will see how each participant is doing with the study treatment during regular visits at the study clinic. The study team will continue to follow-up with participants after study treatment with telephone contacts (or visits). The study will compare the experiences of people receiving elranatamab to those people receiving a combination therapy. This will help learn about the safety and how effective elranatamab is.

Conditions

  • Multiple Myeloma

Interventions

  • ElranatamabDrug

    Elranatamab will be administered subcutaneously

  • ElotuzumabDrug

    Elotuzumab will be administered intravenously

  • PomalidomideDrug

    Pomalidomide will be administered orally

  • DexamethasoneDrug

    Dexamethasone will be administered orally

  • BortezomibDrug

    Bortezomib will be administered subcutaneously or intravenously

  • CarfilzomibDrug

    Carfilzomib will be administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression free survival per International Myeloma Working Group criteriaTime frame: Up to approximately 5 years

Locations

268 sites in 27 countries. Site status is shown where the registry gives one.

  • Infirmary Cancer Care

    Mobile, Alabama · Recruiting

  • Beverly Hills Cancer Center

    Beverly Hills, California · Recruiting

  • Clovis Community Medical Center

    Clovis, California · Recruiting

  • Community Cancer Institute

    Clovis, California · Recruiting

  • Clinical Research Advisors (Encino Satellite Location)

    Encino, California · Recruiting

  • University of California San Francisco

    Fresno, California · Recruiting

  • Community Regional Medical Center

    Fresno, California · Recruiting

  • Hoag Health Center Irvine

    Irvine, California · Active not recruiting

  • Hoag Hospital Irvine

    Irvine, California · Active not recruiting

  • Clinical Research Advisors (Korea Town Satellite Location)

    Los Angeles, California · Recruiting

  • Clinical Research Advisors (West Hollywood Satellite Location)

    Los Angeles, California · Recruiting

  • Valkyrie Clinical Trials

    Los Angeles, California · Recruiting

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California · Active not recruiting

  • Mission Community Hospital (Satellite Site)

    Panorama City, California · Recruiting

  • University of California Davis (UC Davis) Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • University of California

    Sacramento, California · Recruiting

  • UCHealth Poudre Valley Hospital

    Fort Collins, Colorado · Recruiting

  • UCHealth Harmony

    Fort Collins, Colorado · Recruiting

  • UCHealth Greeley Hospital

    Greeley, Colorado · Recruiting

  • UCHealth Longs Peak Hospital

    Longmont, Colorado · Recruiting

  • UCHealth Longs Peak Medical Center

    Longmont, Colorado · Recruiting

  • UCHealth - Medical Center of the Rockies

    Loveland, Colorado · Recruiting

  • Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center

    Coral Gables, Florida · Recruiting

  • University of Miami Hospital and Clinics - Deerfield Beach

    Deerfield Beach, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center- Doral

    Doral, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center - Hollywood

    Hollywood, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center

    Miami, Florida · Recruiting

  • University of Miami Hospital and Clinics - Griffin Cancer Research Building

    Miami, Florida · Recruiting

  • University of Miami Hospital and Clinics

    Miami, Florida · Recruiting

  • Baptist Hospital of Miami

    Miami, Florida · Recruiting

  • Miami Cancer Institute at Baptist Health, Inc.

    Miami, Florida · Recruiting

  • Sylvester Comprehensive Cancer Center- Kendall

    Miami, Florida · Recruiting

  • BRCR Global

    Plantation, Florida · Recruiting

  • BRCR Medical Center Inc

    Plantation, Florida · Recruiting

  • Brcr Medical Center, Inc.

    Plantation, Florida · Recruiting

  • HCA Florida Westside Hospital

    Plantation, Florida · Recruiting

  • BRCR Medical Center Inc.

    Tamarac, Florida · Recruiting

  • Endeavor Health - Swedish Hospital

    Chicago, Illinois · Recruiting

  • Endeavor Health - Evanston Hospital

    Evanston, Illinois · Recruiting

  • Endeavor Health - Glenbrook Hospital Ambulatory Care Center

    Glenview, Illinois · Recruiting

Showing 40 of 268 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.